Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Homogeneity Testing at Different Stages – V 2.0

Posted on By

SOP for Homogeneity Testing at Different Stages – V 2.0

Procedure for Homogeneity Testing at Different Stages

Department Quality Control (QC)/Quality Assurance (QA)/Production
SOP No. SOP/Ointment/036
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic process for homogeneity testing at different stages of ointment manufacturing. Homogeneity testing ensures uniform distribution of active ingredients, consistency, and quality compliance.

2. Scope

This SOP applies to all ointment batches produced in the manufacturing facility, covering pre-mixing, final mixing, cooling, and filling stages.

3. Responsibilities

  • Production Supervisor: Ensures samples are collected at required intervals.
  • QC Analyst: Conducts homogeneity testing as per batch specifications.
  • QA Personnel: Reviews test results and ensures compliance with GMP standards.
  • R&D Scientist: Defines homogeneity testing parameters for each formulation.
See also  Ointments: SOP for Documentation of Cleaning Processes - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that homogeneity testing is conducted as per GMP standards and properly documented.

5. Procedure

5.1 Sampling for Homogeneity Testing

  • Collect representative samples from different parts of the batch:
    • Top
    • Middle
    • Bottom
    • Edges of the mixing vessel
  • Ensure aseptic handling of samples to avoid contamination.
  • Label samples with batch number, sampling location, and stage.

5.2 Homogeneity Testing at Different Stages

5.2.1 Pre-Mixing Stage

  • Verify uniform dispersion of active ingredients before heating.
  • Perform visual inspection for any signs of separation.
  • Check the initial viscosity of the batch.

5.2.2 Final Mixing Stage

  • Perform pH and viscosity testing to confirm uniformity.
  • Check for particle size distribution using a suitable analyzer.
  • Compare test results with pre-defined batch specifications.

5.2.3 Cooling Stage

  • Check for phase separation or crystallization.
  • Perform homogeneity testing for emulsions.
  • Ensure uniform consistency across all sampling locations.
See also  Ointments: SOP for Installation Qualification (IQ) of Equipment - V 2.0

5.2.4 Filling Stage

  • Test for weight variation to ensure uniform filling.
  • Analyze random filled containers to confirm content uniformity.
  • Perform final physical and chemical analysis before batch release.

5.3 Acceptance Criteria for Homogeneity

  • Active ingredient distribution should be within ±5% of the target concentration.
  • pH and viscosity must match the batch specification.
  • No signs of phase separation, air entrapment, or inconsistencies.
  • Test results should comply with pharmacopeial requirements (USP, BP, IP).

5.4 Documentation and Approval

  • Record test results in the Homogeneity Test Log.
  • QA must verify and approve homogeneity before batch release.
  • Retain test samples for stability analysis if required.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • USP – United States Pharmacopeia
  • BP – British Pharmacopeia
  • IP – Indian Pharmacopeia

7. Documents

  • Homogeneity Test Log (Annexure-1)
  • In-Process Quality Control Report (Annexure-2)
See also  Ointments: SOP for Photostability Testing of Ointments - V 2.0

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 211 – Current Good Manufacturing Practices
  • USP/BP/IP Standard Test Methods

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Homogeneity Test Log

Date Batch Number Sampling Location Test Parameter Specification Result Verified By
01/02/2025 SOP/Ointment/001 Top Active Ingredient % 95-105% 98% QA Officer
02/02/2025 SOP/Ointment/002 Bottom pH 5.5-7.0 6.3 QA Officer

Annexure-2: In-Process Quality Control Report

Date Batch Number Stage Test Parameter Specification Result Final Status
01/02/2025 SOP/Ointment/001 Final Mixing Viscosity 1000-2000 cP 1500 cP Pass
02/02/2025 SOP/Ointment/002 Cooling Phase Separation None None Pass

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Preparing Monthly EHS Performance Reports
Next Post: SOP for Maintaining Maintenance Records for Safety Equipment

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version